Celldex Therapeutics
CLDX
#4701
Rank
C$2.70 B
Marketcap
C$40.69
Share price
-0.51%
Change (1 day)
11.34%
Change (1 year)

Revenue for Celldex Therapeutics (CLDX)

Revenue in 2025 (TTM): C$3.67 Million

According to Celldex Therapeutics's latest financial reports the company's current revenue (TTM ) is C$3.59 Million. In 2024 the company made a revenue of C$10.07 Million an increase over the revenue in the year 2023 that were of C$9.12 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Celldex Therapeutics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$3.67 M-63.47%
2024 C$10.07 M10.34%
2023 C$9.12 M185.44%
2022 C$3.19 M-46.05%
2021 C$5.92 M-37.31%
2020 C$9.45 M102.66%
2019 C$4.66 M-64.08%
2018 C$12.98 M-18.92%
2017 C$16.02 M75.71%
2016 C$9.11 M19.92%
2015 C$7.6 M82.71%
2014 C$4.16 M-4.91%
2013 C$4.37 M-60.71%
2012 C$11.13 M18.2%
2011 C$9.42 M-79.85%
2010 C$46.77 M192.84%
2009 C$15.97 M76.2%
2008 C$9.06 M231.4%
2007 C$2.73 M-52.36%
2006 C$5.74 M59.68%
2005 C$3.59 M-56.35%
2004 C$8.23 M37.07%
2003 C$6 M-43.25%
2002 C$10.58 M98.67%
2001 C$5.33 M366.17%
2000 C$1.14 M-44.61%
1999 C$2.06 M-38.97%
1998 C$3.38 M82.11%
1997 C$1.85 M13.01%
1996 C$1.64 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
C$3.17 B 88,375.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.14 B 4,008.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.03 B 28,773.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$49.69 B 1,383,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$86.73 B 2,414,746.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$58.51 B 1,628,852.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA